Post by VectorY

We are looking forward to joining the ALS community at ENCALS 2026! Tomorrow, on Wednesday 24th June, our team will share updates about VTx-002, our investigational vectorized antibody that is designed to target TDP-43, a key protein implicated in most ALS cases. We're pleased to contribute to the scientific dialogue, exchange knowledge, and strengthen collaborations. If you are attending ENCALS 2026, we look forward to connecting with you! Together, we can work toward a future where ALS can be effectively treated. #VectorY #ALS #ALSResearch #ALScommunity #ClinicalTrials #NeurodegenerativeDiseases #vectorizedantibodies #AntibodyTreatments #AntibodyTechnology #ENCALS2026